How to Buy Cannabis Stocks

Trading the hottest cannabis stocks is easier than you think. Buy or sell CFDs on the shares of leading growers through FPMarkets.com with flexible leverage.

Aphria Inc.

Aphria Inc. is a licensed Canadian producer and distributor of medical marijuana with revenue of C$543.3 million in 2020, an increase of 129% on the previous year. It grows cannabis from its plant in Leamington, Ontario, and has announced plans to expand into the U.S. In December 2020, it announced its intention to merge with Tilray.

Trade CFDs  Visit website

Tilray Inc.

Tilray Inc. is a Canadian pharmaceutical company that produces cannabis oil extracts as well as dried cannabis in the form of flowers and blends of ground cannabis. It generated revenues of C$217.4 million in 2019, up 287.2% on the previous year from operations spanning Australia, New Zealand, Canada, Germany and Portugal.

Trade CFDs Visit website

Aurora Cannabis Inc.

Aurora Cannabis Inc. is a licensed Canadian producer and distributor of medical marijuana with revenue of C$278 million in 2020. It is one of the largest cannabis companies with a funded production capacity in excess of 500,000 kilograms per year. Its product range includes cannabis oils, dried cannabis as well as softgels.

Trade CFDs Visit website

Canopy Growth Corporation

Canopy Growth Corporation (formerly Tweed Marijuana Inc.): a cannabis company based in Ontario, Canada, with revenue of C$440 million in 2020. CGC owns cannabis growers and has struck partnerships with overseas pharmaceutical producers and distributors. Shares in Canopy Growth rose sharply in 2018 after a $4 billion investment from Corona-maker Constellation Brands. Since, it has announced plans to expand production into the U.S.

Trade CFDs Visit website

GW Pharmaceuticals plc

GW Pharmaceuticals plc is a British pharmaceutical manufacturer of medicines derived from the cannabis plant, including the first cannabinoid drug approved by the U.S. Food and Drug Administration (FDA). The company generated revenues of $311 million in 2019.

 Trade CFDs  Visit website

Cronos Group Inc.

Cronos Group Inc. (formerly PharmaCan Capital Corp) is a licensed Canadian pharmaceutical manufacturer of medical and recreational cannabis, headquartered in Toronto. It sells cannabis oils, dried cannabis and pre-rolls through wholesale and direct-to-client channels. It generated revenues of C$23.4 million in 2019, up marginally on the previous year.

Trade CFDs Visit website